Keurig Dr Pepper stock gains flexibility as Chobani deal unlocks cash

Keurig Dr Pepper stock is back in the spotlight as the beverage group agrees to sell its Chobani stake and a Pennsylvania facility for USD 925 million, while analysts reaffirm a buy rating with a USD 39 target price.

Keurig Dr Pepper (ISIN US49271V1008) stock is drawing attention after the company agreed to sell its equity stake in yogurt maker Chobani and a manufacturing facility in Pennsylvania for a combined USD 925 million, a move reported on September 3, 2026, that will free up cash for debt reduction and strategic flexibility. According to a report by Ground News summarizing the transaction, Keurig Dr Pepper plans to use the proceeds as it prepares to separate into two listed entities, Beverage Co. and Global Coffee Co., by early next year.

USD 925 million deal strengthens balance sheet

In the deal announced in early September 2026, Keurig Dr Pepper will sell its full equity stake in Chobani for USD 800 million and divest its Allentown, Pennsylvania manufacturing facility for USD 125 million, adding up to USD 925 million in pre-tax proceeds according to the same Ground News report dated September 3, 2026. The company intends to use these funds primarily to reduce debt, which can lower interest expense and improve leverage ratios ahead of its planned split into Beverage Co. and Global Coffee Co. in early 2027, as outlined in the deal coverage.

For investors, the structure of the transaction matters as much as the headline figure: the equity sale delivers USD 800 million in cash and removes exposure to a non-core yogurt business, while the USD 125 million facility sale monetizes a physical asset in Pennsylvania without changing Keurig Dr Pepper’s core beverage and coffee portfolio. By reallocating USD 925 million into debt reduction, the company can potentially improve its net debt to EBITDA ratio in upcoming reporting periods, even though exact leverage metrics were not detailed in the latest transaction summary.

Analysts keep a positive view on Keurig Dr Pepper stock

Alongside the strategic move, analyst sentiment toward Keurig Dr Pepper stock remains constructive. According to an update on September 3, 2026 from investment bank Bernstein reported via Futunn, analyst Cristian Rios maintained a buy rating on Keurig Dr Pepper shares and reiterated a target price of USD 39. This unchanged target underscores that at least one major analyst house views the Chobani transaction and the upcoming corporate split as consistent with a positive medium-term equity story rather than as reasons to turn cautious.

If Keurig Dr Pepper stock were trading at a discount to the USD 39 target as of early September 2026, the reaffirmed valuation would imply upside potential from current levels; if the shares were near that mark, the rating would instead signal confidence that the company can sustain its valuation despite the restructuring. While the exact share price and market capitalization as of September 3, 2026 are not detailed in the same sources, the confirmed target gives investors a numerical reference point when comparing Keurig Dr Pepper to large North American peers such as Coca-Cola or PepsiCo that also operate in the beverages and ready-to-drink segments.

Coffee systems and soft drinks as core business

Keurig Dr Pepper’s business is built on a combination of at-home coffee systems and branded soft drinks, and the planned split into Beverage Co. and Global Coffee Co. is intended to sharpen this dual focus. Beverage Co. is expected to include well-known soft drink and ready-to-drink brands such as Dr Pepper and Canada Dry, while Global Coffee Co. would concentrate on Keurig single-serve coffee systems and related beverage solutions. The sale of the Chobani stake, which generated USD 800 million in cash as noted in the September 3, 2026 transaction coverage, highlights how the group is willing to exit non-core categories like yogurt in order to streamline around beverages and coffee.

Keurig Dr Pepper stock in an international context

For international investors, Keurig Dr Pepper stock trades primarily in the United States, but it is often followed alongside European beverage and consumer staples names. While no specific DACH trading venue listing is highlighted in the latest sources, Keurig Dr Pepper competes indirectly with beverage groups that are included in major indices where German and Swiss investors are active, and the reaffirmed USD 39 target from Bernstein on September 3, 2026 provides a concrete yardstick for cross-market comparisons.

Keurig Dr Pepper at a glance

• Company: Keurig Dr Pepper Inc.
• ISIN: US49271V1008
• Ticker: KDP
• Trading venue: NASDAQ
• Sector / Industry: Beverages / Non-Alcoholic Drinks
• Index membership: S&P 500